Gastroenterology
Neuropilin-1 is an angiogenesis induction factor in human colon cancers
Published in Gene Therapy Weekly, July 29th, 2004
"Neuropilin-1 (NRP-1), a recently identified coreceptor for vascular endothelial growth factor (VEGF), is expressed by several non-gastrointestinal tumor types and enhances prostate cancer angiogenesis and growth in preclinical models. We investigated the expression and regulation of NRP-1 and the effect of NRP-1 overexpression on angiogenesis and growth of human colon adenocarcinoma by immunohistochemistry and in situ hybridization," scientists writing in the American Journal of Pathology report.
"NRP-1 was expressed in 20 of 20 human colon adenocarcinoma specimens but...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-07-29)
More Articles from Gene Therapy Weekly
- Drug Resistance
Bcl-2 antisense agent G3139 invokes a response to refractory multiple myeloma - Gene Regulation
Modified nucleotides defeat barriers to RNA inaccessibility - Gene Transfer
An overnight transduction protocol prepares repopulating cells for transfer - Genetic Engineering
New compounds coax embryonic stem cells into cardiac differentiation - Immunology
CD40 ligand gene therapy halts Th2-mediated tumor escape - Bioengineering
Re-engineered coagulation factor will improve hemophilia A gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
